The incorporation of comorbidities in the prognostication of patients with lower-risk myelodysplastic syndrome*
- 2 December 2016
- journal article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 58 (8), 1893-1902
- https://doi.org/10.1080/10428194.2016.1267350
Abstract
Chronic medical diseases, evaluated by several comorbidities indexes have been reported to influence on overall survival in patients with myelodysplastic syndrome (MDS). However, these studies included patients with lower and higher-risk disease by IPSS. This study retrospectively evaluates the role of comorbidities (evaluated by the MDS comorbidity index; MDS-CI) together with clinical parameters in a series of 232 patients with LR-MDS (defined as either an IPSS score of low/intermediate-1 and favorable cytogenetic categories by IPSS-R). In multivariate analysis, together with age >75 years, diabetes requiring therapy and hemoglobin p< 0.0001) were independently associated to the probability of nonleukemic death (NLD). The combination of these variables allowed development of a model, which categorizes patients in three different groups with significantly different probability of NLD overtime (p< 0.001). This integrated score confirms the importance of comorbidities at diagnosis of patients with LR-MDS.Keywords
This publication has 30 references indexed in Scilit:
- Development of a Six-Month Prognostic Index in Patients With Advanced Chronic Medical Conditions: The PALIAR ScoreJournal of Pain and Symptom Management, 2014
- Clinical Prognostic Factors for Survival and Risk of Progression to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndromes With < 10% Marrow Blasts and Non-Unfavorable Cytogenetic CategoriesClinical Lymphoma Myeloma and Leukemia, 2013
- Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic ModelJournal of Clinical Oncology, 2011
- Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndromeHaematologica, 2010
- Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study GroupAnnals of Oncology, 2010
- Comorbidities and survival in a large cohort of patients with newly diagnosed myelodysplastic syndromesLeukemia Research, 2009
- A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcomeBlood, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987